SEC Form 4 · accession 0001144204-17-020445
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susanne Wilke
Officer — Chief Executive Officer · Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 13, 2017 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $19.62 | Apr 11, 2017 | A | 62,500 | A | — | Apr 11, 2027 | Common Stock | 62,500 | 62,500 | D |
Explanation of responses
- F1Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted.
- F2The stock options vest in equal quarterly installments over a three-year period.